Axsome Therapeutics (AXSM) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05464T1043
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on creating innovative treatments for central nervous system disorders in the United States.
The company's product lineup consists of Auvelity for major depressive disorder and Sunosi for daytime sleepiness in patients with narcolepsy or sleep apnea.
Axsome Therapeutics is actively working on AXS-05 for Alzheimer's agitation and smoking cessation, AXS-07 for migraine, AXS-12 for narcolepsy, AXS-14 for fibromyalgia, and solriamfetol for ADHD.
Additionally, Axsome has a research partnership with Duke University to study AXS-05 in smoking cessation. The company, established in 2012, is headquartered in New York. Learn more about their work at https://www.axsome.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
AXSM Stock Overview
| Market Cap in USD | 3,423m |
| Sector | Healthcare |
| Industry | Biotechnology |
| GiC SubIndustry | Pharmaceuticals |
| TER | 0.00% |
| IPO / Inception | 2015-11-19 |
AXSM Stock Ratings
| Growth 5y | 4.12 |
| Fundamental | -5.19 |
| Dividend | - |
| Rel. Performance vs Sector | -1.09 |
| Analysts | 4.56/5 |
| Fair Price Momentum | 63.86 USD |
| Fair Price DCF | - |
AXSM Dividends
| Yield 12m | 0.00% |
| Yield on Cost 5y | 0.00% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 0.0% |
AXSM Growth Ratios
| Growth 12m | -6.88% |
| Growth Correlation 12m | 5% |
| Growth Correlation 3m | -63% |
| CAGR 5y | 34.91% |
| Sharpe Ratio 12m | -0.26 |
| Alpha vs SP500 12m | -27.54 |
| Beta vs SP500 5y weekly | 0.93 |
| ValueRay RSI | 16.83 |
| Volatility GJR Garch 1y | 65.10% |
| Price / SMA 50 | -12.85% |
| Price / SMA 200 | -9.25% |
| Current Volume | 930.8k |
| Average Volume 20d | 609.4k |
External Links for AXSM Stock
News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
What is the price of AXSM stocks?
As of April 20, 2024, the stock is trading at USD 67.90 with a total of 930,832 shares traded.
Over the past week, the price has changed by -1.81%, over one month by -11.67%, over three months by -20.07% and over the past year by -5.89%.
As of April 20, 2024, the stock is trading at USD 67.90 with a total of 930,832 shares traded.
Over the past week, the price has changed by -1.81%, over one month by -11.67%, over three months by -20.07% and over the past year by -5.89%.
What is the forecast for AXSM stock price target?
According to ValueRays Forecast Model, AXSM Axsome Therapeutics will be worth about 71.1 in April 2025. The stock is currently trading at 67.90. This means that the stock has a potential upside of +4.7%.
According to ValueRays Forecast Model, AXSM Axsome Therapeutics will be worth about 71.1 in April 2025. The stock is currently trading at 67.90. This means that the stock has a potential upside of +4.7%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 123.1 | 81.3% |
| Analysts Target Price | 116.5 | 71.5% |
| ValueRay Target Price | 71.1 | 4.70% |